- news, features, articles and disease information for the swine industry


Boehringer Ingelheim, Sanofi in Contract Manufacturing Alliance

23 January 2015
Boehringer Ingelheim

GERMANY - Boehringer Ingelheim and Sanofi have entered into an alliance to extend Sanofi’s manufacturing capacity network for therapeutic monoclonal antibodies.

Boehringer Ingelheim’s cell culture operations will provide contract manufacturing capacities to support the production of Sanofi’s biologics pipeline.

Under the terms of the agreement, Sanofi will have access to Boehringer Ingelheim’s capabilities to transfer and manufacture therapeutic monoclonal antibodies for global market supply.

Initial product transfers will begin in early 2015.

ThePigSite News DeskRead more Boehringer Ingelheim News here

Share This

News By

Related News

More News

Swine fever cover-ups continue

News from China   23 January 2019

Our Sponsors


Seasonal Picks

Animal Welfare Science, Husbandry and Ethics: The Evolving Story of Our Relationship with Farm Animals - 5m Books